Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.10.0.1
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Segment Reporting Information [Line Items]          
Total revenues $ 263,685 $ 292,601 $ 518,598 $ 558,981  
Operating loss (5,108) (25,831) (47,719) (71,047)  
Depreciation and amortization 24,762 25,551 49,518 51,281  
Net income (loss) from investment in investees (7,213) (5,628) (9,669) (7,758)  
Assets 2,530,950   2,530,950   $ 2,589,956
Goodwill 714,234   714,234   717,099
United States          
Segment Reporting Information [Line Items]          
Total revenues 222,535 244,650 437,845 474,084  
Ireland          
Segment Reporting Information [Line Items]          
Total revenues 20,778 22,525 38,060 39,734  
Chile          
Segment Reporting Information [Line Items]          
Total revenues 11,937 11,899 23,670 22,020  
Spain          
Segment Reporting Information [Line Items]          
Total revenues 4,592 5,118 10,125 9,623  
Israel          
Segment Reporting Information [Line Items]          
Total revenues 2,526 7,654 6,141 11,872  
Mexico          
Segment Reporting Information [Line Items]          
Total revenues 1,302 724 2,723 1,589  
Other          
Segment Reporting Information [Line Items]          
Total revenues 15 31 34 59  
Corporate          
Segment Reporting Information [Line Items]          
Operating loss (8,748) (12,878) (20,393) (28,849)  
Depreciation and amortization 21 30 51 60  
Net income (loss) from investment in investees 0 0 0 0  
Assets 55,201   55,201   60,604
Goodwill 0   0   0
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss 2,165 (8,009) (20,783) (34,154)  
Depreciation and amortization 6,752 6,694 13,492 13,469  
Net income (loss) from investment in investees (6,942) (5,309) (9,114) (7,123)  
Assets 1,258,293   1,258,293   1,287,964
Goodwill 261,447   261,447   264,313
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss 1,475 (4,944) (6,543) (8,044)  
Depreciation and amortization 17,989 18,827 35,975 37,752  
Net income (loss) from investment in investees (271) (319) (555) (635)  
Assets 1,217,456   1,217,456   1,241,388
Goodwill 452,787   452,787   $ 452,786
Services          
Segment Reporting Information [Line Items]          
Total revenues 216,055 233,912 427,369 462,456  
Services | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 216,055 233,912 427,369 462,456  
Products          
Segment Reporting Information [Line Items]          
Total revenues 28,523 28,966 56,374 51,197  
Products | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 28,523 28,966 56,374 51,197  
Transfer of intellectual property and other          
Segment Reporting Information [Line Items]          
Total revenues 19,107 29,723 34,855 45,328  
Transfer of intellectual property and other | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Transfer of intellectual property and other | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 19,107 29,723 34,855 45,328  
Transfer of intellectual property and other | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues $ 0 $ 0 $ 0 $ 0